OP0219 Early onset of efficacy with apremilast monotherapy in biologic-naÏve patients with active psoriatic arthritis: a phase 3b, randomized, controlled trialPeter Nash, Aelion Ja, Jessica A. Walsh et al.|Annals of the Rheumatic Diseases|2017Cited by 3